Board MeetingOutcome of Board Meeting
Krebs Biochemicals' board has approved the financial results for the quarter ended June 30, 2026.
Krebs Biochemicals and Industries LimitedKREBSBIO · Filed with the exchange
No comments yet. Be the first.
No comments yet. Be the first.